[HTML][HTML] Emerging therapeutic strategies for Parkinson's disease and future prospects: A 2021 update

NA Gouda, A Elkamhawy, J Cho - Biomedicines, 2022 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disorder pathologically distinguished by
degeneration of dopaminergic neurons in the substantia nigra pars compacta. Muscle …

Understanding the links between cardiovascular disease and Parkinson's disease

J Potashkin, X Huang, C Becker, H Chen… - Movement …, 2020 - Wiley Online Library
Studies investigating the associations between genetic or environmental factors and
Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular …

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics

K Senkevich, Z Gan-Or - Parkinsonism & related disorders, 2020 - Elsevier
In recent years, multiple lines of evidence from human genetic and molecular studies have
highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's …

The vicious cycle between αsynuclein aggregation and autophagiclysosomal dysfunction

G Bellomo, S Paciotti, L Gatticchi… - Movement …, 2020 - Wiley Online Library
The accumulation and misfolding of αsynuclein (αsyn) represent the main pathological
hallmark of PD. Overexpression of αsyn and failure of cellular protein degradation systems …

[HTML][HTML] The relationship of alpha-synuclein to mitochondrial dynamics and quality control

NJ Thorne, DA Tumbarello - Frontiers in molecular neuroscience, 2022 - frontiersin.org
Maintenance of mitochondrial health is essential for neuronal survival and relies upon
dynamic changes in the mitochondrial network and effective mitochondrial quality control …

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease

Y Oji, T Hatano, SI Ueno, M Funayama, K Ishikawa… - Brain, 2020 - academic.oup.com
Recently, the genetic variability in lysosomal storage disorders has been implicated in the
pathogenesis of Parkinson's disease. Here, we found that variants in prosaposin (PSAP), a …

Delivering the promise of gene therapy with nanomedicines in treating central nervous system diseases

M Luo, LKC Lee, B Peng, CHJ Choi… - Advanced …, 2022 - Wiley Online Library
Abstract Central Nervous System (CNS) diseases, such as Alzheimer's diseases (AD),
Parkinson's Diseases (PD), brain tumors, Huntington's disease (HD), and stroke, still remain …

Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond

AN Bayne, JF Trempe - Cellular and Molecular Life Sciences, 2019 - Springer
Parkinson's disease (PD) is a degenerative movement disorder resulting from the loss of
specific neuron types in the midbrain. Early environmental and pathophysiological studies …

[HTML][HTML] Alpha-synuclein and lipids: the elephant in the room?

A Sarchione, A Marchand, JM Taymans… - Cells, 2021 - mdpi.com
Since the initial identification of alpha-synuclein (α-syn) at the synapse, numerous studies
demonstrated that α-syn is a key player in the etiology of Parkinson's disease (PD) and other …

[HTML][HTML] A practical approach to early-onset Parkinsonism

GM Riboldi, E Frattini, E Monfrini… - Journal of …, 2022 - content.iospress.com
Early-onset parkinsonism (EO parkinsonism), defined as subjects with disease onset before
the age of 40 or 50 years, can be the main clinical presentation of a variety of conditions that …